Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding
Nonsteroidal anti-inflammatory drugs reduce heavy menstrual bleeding compared to placebo but are less effective than tranexamic acid or danazol, with fewer adverse effects than danazol.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (72)
- 6 Dysfunctional uterine bleeding via openalex
- A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia via openalex
- An Objective Evaluation of Flurbiprofen and Tranexamic Acid in the Treatment of Idiopathic Menorrhagia via openalex
- Benefits and Risks of Pharmacological Agents Used for the Treatment of Menorrhagia via openalex
- Comparison between mefenamic acid and danazol in the treatment of established menorrhagia via openalex
- Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid via openalex
- Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia via openalex
- Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex
- Endometrial prostaglandins and menorrhagia: influence of a prostaglandin synthetase inhibitor in vivo via openalex
- FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age via openalex
- Financial and Quality-of-Life Burden of Dysfunctional Uterine Bleeding Among Women Agreeing To Obtain Surgical Treatment via openalex
- Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia via openalex
- Levonorgestrel Intrauterine System versus Medical Therapy for Menorrhagia via openalex
- Management of Cyclical Menorrhagia with Prostaglandin Synthetase Inhibitor via openalex
- Primary and myoma‐associated menorrhagia: role of prostaglandins and effects of ibuprofen via openalex
- Prostaglandins and Menorrhagia via openalex
- PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING via openalex
- Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of Menorrhagia via openalex
- REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS via openalex
- Role of Non-Steroidal Anti-Inflammatory Drugs in Gynecology via openalex
- STUDIES IN THE INVOLVEMENT OF PROSTAGLANDINS IN UTERINE SYMPTOMATOLOGY AND PATHOLOGY via openalex
- The effects of danazol mefanamic acid, norethistherone and a progesterone-impragnated coil on endometrial prostaglandin concentrations in women with monorrhagia via openalex
- The role of prostaglandins and allied substances in uterine haemostasis via openalex
- doi:10.1186/1745-6215-12-264 via openalex
- doi:10.1111/j.1471-0528.2005.00642.x via openalex
- W2145665335 via openalex
- W2272204407 via openalex
- W2412929396 via openalex
- W2413652508 via openalex
- W6602010017 via openalex
- W6602328082 via openalex
- W6602545331 via openalex
- W6607729374 via openalex
- W6715743702 via openalex
- doi:10.1017/cbo9781107445208.003 via openalex
- doi:10.1016/s0140-6736(81)92051-1 via openalex
- doi:10.1136/bmj.d5928 via openalex
- doi:10.1783/147118904322995537 via openalex
- doi:10.1192/bjp.140.4.335 via openalex
- doi:10.1111/j.1471-0528.1977.tb12490.x via openalex
- doi:10.1016/j.ijgo.2014.09.027 via openalex
- doi:10.1016/0010-7824(77)90026-9 via openalex
- doi:10.1097/00006254-198205000-00015 via openalex
- doi:10.1111/j.1471-0528.1991.tb13460.x via openalex
- doi:10.1136/bmj.327.7414.557 via openalex
- doi:10.1016/s0140-6736(98)12154-2 via openalex
- doi:10.1016/s0002-9378(87)80093-5 via openalex
- doi:10.1097/01.gco.0000175361.12470.3b via openalex
- doi:10.2165/00002018-200831040-00001 via openalex
- doi:10.1016/j.mayocp.2011.11.002 via openalex
- doi:10.1677/joe.0.1290439 via openalex
- doi:10.1016/j.fertnstert.2005.04.062 via openalex
- W3470488 via openalex
- W51706072 via openalex
- W63062164 via openalex
- W102289126 via openalex
- W191591924 via openalex
- doi:10.1016/j.ajog.2003.11.016 via openalex
- doi:10.1111/j.1524-4733.2007.00168.x via openalex
- doi:10.1016/j.ajog.2003.11.015 via openalex
- doi:10.1111/j.1471-0528.1980.tb05018.x via openalex
- doi:10.1111/j.1471-0528.1990.tb16249.x via openalex
- doi:10.1136/bmj.313.7057.579 via openalex
- doi:10.1111/j.1471-0528.1980.tb05013.x via openalex
- doi:10.1111/j.1471-0528.1971.tb00208.x via openalex
- doi:10.1111/j.1471-0528.1992.tb13758.x via openalex
- doi:10.3109/00016346609158455 via openalex
- doi:10.1016/s0029-7844(01)01581-2 via openalex
- doi:10.1111/j.1471-0528.1995.tb11398.x via openalex
- doi:10.1111/j.1471-0528.2001.00020.x via openalex
- doi:10.5694/j.1326-5377.1940.tb79957.x via openalex
- doi:10.1016/0002-9378(84)90123-6 via openalex
Cited by (31)
- Prostaglandin E2 regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding 2024
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- The Menstrual Endometrium: From Physiology to Future Treatments 2022
- Blutungsstörungen, Dysmenorrhö und Endometriose im Jugendalter 2021
- Endometriosis and Uterine Fibroids (Leiomyomata): Comorbidity, Risks and Implications 2021
- NSAIDs for heavy menstrual bleeding 2021
- A physiatrist's understanding and application of the current literature on chronic pelvic pain: a narrative review 2021
- Celecoxib, a selective COX‑2 inhibitor, markedly reduced the severity of tamoxifen‑induced adenomyosis in a murine model 2020
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2019
- [Progress on medical treatment in the management of adenomyosis]. 2019
- Abnormal Uterine Bleeding 2017
- Management of endometrial modifications in perimenopausal women 2015
- Levonorgestrel-Releasing Intrauterine System versus Medical Therapy for Menorrhagia: A Systematic Review and Meta-Analysis 2014
- Effect of Ginger (<i>Zingiber officinale</i>) on Heavy Menstrual Bleeding: A Placebo‐Controlled, Randomized Clinical Trial 2014
- Menstrual Problems for the MRCOG and Beyond 2014
- EMAS position statement: Management of uterine fibroids 2014
- Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest 2013
- Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM) 2013
- Adenomyosis: A Challenge in Clinical Gynecology 2012
- Hysterectomy and levonorgestrel-releasing intrauterine system in the treatment of menorrhagia : a 10-year randomized comparative trial 2012
- Abnorme uterine Blutung 2012
- The hyperexpressions of putative stem cells in the eutopic endometrium of patients with advanced endometriosis 2010
- Role of Non-Steroidal Anti-Inflammatory Drugs in Gynecology 2010
- Activation of NF-κB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens 2009
- Cortisol Inactivation by 11β-Hydroxysteroid dehydrogenase-2 May Enhance Endometrial Angiogenesis via Reduced Thrombospondin-1 in Heavy Menstruation 2009
- Hiérarchisation des stratégies thérapeutiques pour ménométrorragies avec ou sans désir de grossesse 2008
- Dismenorreas 2008
- Medical Therapies for Chronic Menorrhagia 2007
- Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use 2006
- Benefits and Risks of Pharmacological Agents Used for the Treatment of Menorrhagia 2004
- Endometrial thermoablation for treatment of menorrhagia: comparison of two methods in outpatient setting 2003
Source provenance
- openalex
- last seen: 2026-05-11T06:22:51.059792+00:00